Skip to main content

Table 1 Patient characteristics following different cardiac and major vascular surgeries

From: The impact of thyroid function on surgical prognosis in patients undergoing cardiac and major vascular surgeries

 

ALL (472)

CABG (173)

AS (131)

VS (125)

PCNR (43)

F-value

p value

Pre-TSH, mIU/L

2.61 ± 2.07

2.69 ± 2.18

2.49 ± 1.65

2.84 ± 2.47

1.98 ± 1.28

2.084

0.101

Pre-FT3, pmol/L

3.81 ± 0.96

3.76 ± 0.9

4.01 ± 1.08

3.71 ± 0.95

3.65 ± 0.77

2.82

0.039

Pre- FT4, pmol/L

13.04 ± 1.88

12.75 ± 1.49

13.11 ± 1.84

13.37 ± 2.36

13.02 ± 1.69

2.825

0.038

Post-TSH, mIU/L

1.12 ± 1.53

1.21 ± 1.97

1.04 ± 1.11

1.05 ± 1.32

1.18 ± 1.13

0.429

0.733

Post-FT3, pmol/L

2.45 ± 0.66

2.42 ± 0.59

2.57 ± 0.64

2.4 ± 0.6

2.39 ± 1.06

1.95

0.121

Post-FT4, pmol/L

11.98 ± 2.57

12.15 ± 2.23

12.21 ± 2.38

11.99 ± 2.45

10.54 ± 4.04

5.191

0.002

Pre-EF, %

58.72 ± 7.77

58.1 ± 8.51

58.49 ± 8.42

58.82 ± 6.48

61.65 ± 5.14

2.478

0.061

Post-EF, %

57.67 ± 9.43

55.54 ± 11.57

59.58 ± 7.7

57.48 ± 8.01

61.02 ± 5.71

6.773

< 0.001

ΔTSH, mIU/L

1.49 ± 1.77

1.48 ± 1.99

1.45 ± 1.27

1.79 ± 2.01

0.8 ± 1.12

3.407

0.018

ΔFT3, pmol/L

1.35 ± 0.92

1.34 ± 0.88

1.44 ± 1.03

1.32 ± 0.84

1.27 ± 0.94

0.571

0.634

ΔFT4, pmol/L

1.06 ± 2.5

0.6 ± 2.14

0.9 ± 2.15

1.39 ± 2.49

2.48 ± 3.9

7.797

< 0.001

ΔEF, %

1.05 ± 5.39

2.55 ± 5.66

-1.04 ± 4.97

1.3 ± 4.9

0.63 ± 4.82

11.979

< 0.001

Total hospital stay, day

19.02 ± 8.33

20.21 ± 10.31

18.92 ± 7.33

19.05 ± 6.29

14.49 ± 5.7

5.579

0.001

Post-hospital stay, day

13.74 ± 6.39

13.82 ± 6.36

15.24 ± 7.42

13.22 ± 5.33

10.33 ± 4.3

7.02

< 0.001

ICU stay, day

2.54 ± 2.97

2.51 ± 2.86

3.34 ± 4.09

2.14 ± 1.78

1.33 ± 0.68

6.489

< 0.001

Duration of mechanical ventilation, hour

19.29 ± 31.76

15.27 ± 18.51

27.39 ± 44.52

18.67 ± 33.61

12.65 ± 10.95

4.506

0.004

Norepinephrine, IU

1.63 ± 2.19

1.69 ± 2.64

1.77 ± 2.06

1.31 ± 1.44

1.93 ± 2.42

1.369

0.252

Dopamine, IU

3.46 ± 3.08

3.33 ± 2.94

3.68 ± 3.13

3.54 ± 2.88

3.07 ± 3.99

0.58

0.628

Epinephrine, IU

1.03 ± 2.06

1.13 ± 2.43

0.97 ± 1.79

1.07 ± 1.88

0.7 ± 1.68

0.57

0.635

Million, IU

0.86 ± 1.69

0.66 ± 1.37

0.8 ± 1.89

1.1 ± 1.7

1.12 ± 2.07

2.086

0.101

Postoperative constipation, level

1.32 ± 1.09

1.29 ± 1.07

1.42 ± 1.15

1.39 ± 1.05

0.93 ± 1.01

2.445

0.063

Postoperative drowsiness, level

1.33 ± 1.11

1.35 ± 1.07

1.44 ± 1.18

1.38 ± 1.08

0.84 ± 1.04

3.404

0.018

Mediastinal drainage, ml

371.03 ± 423.61

453.61 ± 323.94

383.43 ± 601.44

285.96 ± 344.22

248.26 ± 218.22

5.252

0.001

Total diversion volume, ml

387.18 ± 430.73

457.18 ± 325.4

391.4 ± 607.17

304.81 ± 366.49

332.09 ± 256.33

3.335

0.019

  1. Pre: Preoperative; Post: Postoperative; Δ: Change; CABG: Coronary artery bypass grafting; AS: Aortic surgery; VS: Valve surgery; PCNR: Primary cardiac neoplasms resection; TSH: Thyroid-stimulating hormone; FT3: Free triiodothyronine; FT4: Free thyroxine; EF: Ejection fraction
Back to article page

Journal of Cardiothoracic Surgery

ISSN: 1749-8090

Contact us